Editorial
Oxalate-induced arthritis
Chronic renal failure is one of the commonest causes of hyperoxalemia because renal excretion is the sole clearance pathway for oxalate (1, 2) . Oxalate retention leads to supersaturation (3) and crystal formation with deposition in various tissues (1, 4) . Several factors peculiar to renal failure may contribute to this process. It is speculated that intra-articular supersaturation may be precipitated or exacerbated by rapid water resorption from edematous joints during dialysis (5) . Alternatively, supersaturation may result from increased oxalate production from the metabolism of vitamin C, a precursor of oxalic acid frequently given to dialysis patients (6) . Vitamin C administration increases oxalate production through hydrolysis to 2-3 di-keto-L-gluconic acid and further metabolism to Lthreonic and oxalic acids.
A number of studies have implicated hyperoxalemia in arthritogenesis (7, 8) . This is substantiated by the recent finding of calcium-oxalate crystals in the synovial fluid of patients with end stage renal disease (9, 10) , and its demonstration in the synovial cells both during the acute attack and in remission (5, 11) . The pathogenesis of calcium-oxalate induced-arthropathy is believed to be due, as in other crystal-induced arthropathies, to phagocytosis of the crystal by synovial cells and the subsequent release of collagenase and neutral proteases (12) .
Because of the systemic nature of hyperoxalosis, the clinical manifestations are commonly symmetric.
Diffuse involvement of the hands occurs, with intra and periarticular calcified depositions. Occasionally podagra, tenosynovitis, olecranon bursitis, and miliary calcified deposits in the skin may develop (10) . The severity of the condition appears to increase' with time, as shown by more severe oxalate deposition in patients maintained on dialysis for longer periods (4) .
Various nonspecific treatments may alleviate the arthritis. Oral non-steroidal antiinflammatory drugs (NSAIDs) and intra-articular injections of steroids are of benefit. Vitamin C supplementations should be limited to 100 mg per day and foods rich in oxalate precursors should be avoided. The value 'of peritoneal and hemodialysis in lowering oxalate levels and reversing the supersaturation is controversial. While Hoffman et al. (9) reported 40%-60% reduction in serum oxalate levels, other investigators found neither procedure to be effective (10, 11) .
Urate-induced arthritis
Acute gout is characterized by the deposition of monosodium urate crystals in connective tissues. Renal impairment is a common cause of hyperuricemia yet acute gout is uncommon in this population. For deposition of uric acid crystals to occur, a number of factors including changes in pH, alterations in joint cartilage and local temperature playa role and probably have synergistic effects (13) . Moreover, hyperphosphatemia causes calcium/phosphate supersaturation and deposition leading to local changes favouring the precipitation of uric acid crystals (14) . However, the poor tissue inflammatory response in patients with chronic renal failure makes the acute attack a rare phenomenon (15) .
Most of the attacks are acute in onset and gradual in subsidence (16) but some are chronic and mild. They usually-occur in atypical locations (14) . The main joints involved are those of the hands and wrists followed by the shoulders, elbows, ankles, and knees, Crystal induced arthropathy in uremia involving the synovia, tendons, and bursa (14) . Signs of local inflammation are usually apparent.
The attacks are treated by local immobilization and NSAID. Colchicine is also used but the dose must be reduced because of delayed clearance. Intra-articular steroid injections are of great symptomatic benefit when the attack is localized and the joint accessible.
Calcium-pyrophosphate-induced arthritis
Calcium-pyrophosphate deposition, a syndrome referred to as pseudogout, occurs secondary to idiopathic degenerative changes affecting the cartilage (15) . Factors favoring the development of calciumpyrophosphate crystals are elevated pyrophosphate level and secondary hyperparathyroidism, commonly found in chronic renal failure.
The retention of phosphate and an increased calcium-phosphorous product also favour deposition (15) . Although lowering the calcium-phosphorous product would be expected to decrease the incidence of arthropathy, Chalmers et al. (17) observed in 19 patients maintained on continuous ambulatory peritoneal dialysis a paradoxical increase in the frequency of arthropathy rather than a decrease. The reason for this aberrant response is unclear.
The pathogenesis of the pyrophosphate-induced arthropathy is due to phagocytosis of the crystal by synovial cells and the release of collagenase and neutral protease (18) . Major joints are most commonly affected. Radiographically, osteophytes, subchondral cysts, and cartilage loss are seen in the metacarpophalangeals, wrists, and shoulders (19) .
Attacks of pseudogout are treated by immobilization of the affected joint and administration of NSAIDs or steroids. The prophylactic use of NSAIDs is not effective in preventing recurrences, which may be common, and early treatment of individual attacks is preferred over chronic NSAID intake.
Calcium-apatite-induced arthritis
Hemodialysis patients are prone to calciumhydroxyapatite induced arthritis because of: a) secondary hyperparathyroidism (20) ; b) oral and dialytic calcium and alkali supplementation contributing to calcium deposition (21); c) predisposition to metastatic calcifications (21); d) high levels of hydroxyapatite in joint effusions consequent to bone destruction by renal osteodystrophy (22) .
The pathogenesis of the arthropathy is also due to crystal phagocytosis and enzyme release (17) . Schumacher et al. (23) identified the hydroxyapatite crystals by electron microscopy in neutrophil and mononuclear cell vacuoles of patients' synovial fluid. Hydroxyapatite was also found to activate the alternate complement pathway, resulting in the production of complement-induced chemotaxis (24) . This might explain the chemotactic activity demonstrated by Yano et al. (22) in the joint effusion of patients with hydroxyapatite-induced arthropathy.
Hydroxyapatite depositions usually affect the periarticular soft tissue, tendon sheaths, the interphalangeal joints, shoulders, hips, and wrists (15) . There are episodic acute attacks associated with joint effusions (22) . The para-articular depositions are generally asymptomatic (20) . The identification of hydroxyapatite crystals in a vertebral disc suggests that these deposits may be associated with destructive spondyloarthropathy (25) .
Dialysis itself does not seem to relieve these diseases. Some of the symptoms, mainly the articular ones, may indeed appear before starting dialysis. Further symptomatic periarticular metastatic depositions can be noted after dialysis is begun (21) . Increasing the frequency of dialysis does not improve symptoms or reduce the depositions (21) . Treatment of the acute attacks with immobilization of the affected joint and aspiration along with NSAID administration is beneficial. However, many attacks resolve spontaneously (15, 23) . 
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